Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NPI 1770659732
NPI deactivated

1770659732

1770659732 was paid $209K by Medicaid between Jan 2018 and Mar 2023, across 49 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 54% of everything it billed.

33Billing provider info1770659732
33aNPI1770659732
33bProvider type—
28Total paid$209K
24GClaims25,024
24DCodes billed49
24AFirst – last monthJan 2018 – Mar 2023
Box 24A · Dates of service

Paid by month

$0$5.0K$10K$15K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201810,009$86K
201912,273$83K
20202,561$38K
202191$2K
202252$0.00
202338$63.61
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 54% 4,061 3,019 $112K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 32% 2,603 2,112 $67K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 5.6% 1,540 1,271 $12K
3008F <1% 1,520 1,149 $2K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 620 497 $2K
J1030 Injection, methylprednisolone acetate, 40 mg <1% 569 489 $2K
1160F <1% 1,469 1,123 $1K
1159F <1% 1,463 1,116 $1K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 201 93 $1K
3074F <1% 980 746 $1K
3078F <1% 898 664 $982.40
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 45 40 $904.99
37 more codes
1125F <1% 1,189 $840.00
36415 Collection of venous blood by venipuncture <1% 1,206 $804.60
90674 <1% 67 $513.56
3079F <1% 303 $450.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 59 $335.40
3077F <1% 198 $330.00
82948 <1% 381 $317.50
81001 <1% 274 $304.61
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 35 $294.53
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 48 $279.64
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 15 $262.15
92551 <1% 35 $229.24
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 231 $213.91
90688 <1% 29 $200.91
3075F <1% 72 $170.00
1126F <1% 132 $150.00
81025 <1% 55 $136.94
3080F <1% 53 $130.00
99173 <1% 54 $95.38
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 91 $88.21
J1020 Injection, methylprednisolone acetate, 20 mg <1% 25 $63.20
80305 <1% 16 $57.64
83036 Hemoglobin; glycosylated (A1C) <1% 135 $33.09
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 34 $24.58
G0008 Administration of influenza virus vaccine <1% 12 $15.42
G8754 Most recent diastolic blood pressure < 90 mmhg 0% 1,247 $0.00
G8755 Most recent diastolic blood pressure >= 90 mmhg 0% 14 $0.00
G9664 Patients who are currently statin therapy users or received an order (prescription) for statin therapy 0% 140 $0.00
G8420 Bmi is documented within normal parameters and no follow-up plan is required 0% 42 $0.00
80502 0% 16 $0.00
G8753 Most recent systolic blood pressure >= 140 mmhg 0% 147 $0.00
G8730 Pain assessment documented as positive using a standardized tool and a follow-up plan is documented 0% 397 $0.00
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 0% 432 $0.00
G8752 Most recent systolic blood pressure < 140 mmhg 0% 1,171 $0.00
G8506 Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy 0% 17 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 0% 589 $0.00
G8731 Pain assessment using a standardized tool is documented as negative, no follow-up plan required 0% 94 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.